Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Gross Profit: 2023-2024

Historic Gross Profit for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Dec 2024 value amounting to $2.3 million.

  • Tonix Pharmaceuticals Holding's Gross Profit rose 51.78% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 50.90%. This contributed to the annual value of $2.3 million for FY2024, which is 23.06% down from last year.
  • According to the latest figures from FY2024, Tonix Pharmaceuticals Holding's Gross Profit is $2.3 million, which was down 23.06% from $3.0 million recorded in FY2023.
  • Tonix Pharmaceuticals Holding's 5-year Gross Profit high stood at $3.0 million for FY2023, and its period low was $2.3 million during FY2024.
  • Over the past 2 years, Tonix Pharmaceuticals Holding's median Gross Profit value was $2.7 million (recorded in 2023), while the average stood at $2.7 million.
  • Data for Tonix Pharmaceuticals Holding's Gross Profit shows a maximum YoY declined of 23.06% (in 2024) over the last 5 years.
  • Tonix Pharmaceuticals Holding's Gross Profit (Yearly) stood at $3.0 million in 2023, then declined by 23.06% to $2.3 million in 2024.